Consolidated statements of income and comprehensive income
(unaudited)
|
Three months ended 31 March |
|
(thousands of €, except share and per share data) |
2017 |
2016 |
Revenues |
33,992 |
10,121 |
Other income |
5,871 |
4,696 |
Total revenues and other income |
39,863 |
14,817 |
|
|
|
Research and development expenditure |
(44,930) |
(27,818) |
General and administrative expenses |
(5,603) |
(3,972) |
Sales and marketing expenses |
(556) |
(422) |
Total operating expenses |
(51,088) |
(32,212) |
|
|
|
Operating loss |
(11,225) |
(17,395) |
|
|
|
Fair value re-measurement of share subscription agreement |
– |
57,479 |
Other financial income |
894 |
626 |
Other financial expenses |
(3,274) |
(4,761) |
|
|
|
Profit / loss (–) before tax |
(13,605) |
35,950 |
|
|
|
Income taxes |
– |
– |
|
|
|
Net income / loss (–) |
(13,605) |
35,950 |
Net income / loss (–) attributable to: |
|
|
Owners of the parent |
(13,605) |
35,950 |
Basic income / loss (–) per share |
(0.29) |
0.81 |
Diluted income / loss (–) per share |
(0.29) |
0.79 |
Weighted average number of shares – basic (in thousands of shares) |
46,256 |
44,425 |
Weighted average number of shares – diluted (in thousands of shares) |
48,330 |
45,492 |
|
Three months ended 31 March |
|
(thousands of €) |
2017 |
2016 |
Net income / loss (–) |
(13,605) |
35,950 |
Items that may be reclassified subsequently to profit or loss: |
|
|
Fair value adjustment of available-for-sale financial assets |
(8) |
|
Translation differences, arisen from translating foreign activities |
39 |
(382) |
Other comprehensive income, net of income tax |
31 |
(382) |
|
|
|
Total comprehensive income attributable to: |
|
|
Owners of the parent |
(13,574) |
35,567 |